CompletedNot Applicable

Effects of Beta-adrenergic in Adults w/Transposition of Great Arteries on Systemic Ventricular Function

United States110 participantsStarted 1997-01

Plain-language summary

The purpose of this chart review study is to examine the effects of beta -adrenergic blocking agents on systemic ventricular dimensions, systemic atrioventricular valve function and exercise tolerance in patients with transposition of the great arteries (TGA) and systemic ventricular dysfunction.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 18 years
✓. Diagnosis: Complete d-TGA or Congenitally Corrected TGA with a systemic morphologic right ventricle
✓. Patients \> 18 years of age seen at The Emory Clinic and Emory University Hospital with transposition of the great arteries
✓. Systemic ventricular ejection fraction \< 50% with or without a clinical diagnosis of heart failure
✓. Echocardiogram performed between January 1, 1997and February 1, 2006

What they're measuring

functional class

Timeframe: 6 months to 5 years

Trial details

NCT IDNCT00313352

SponsorEmory University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2007-03

View on ClinicalTrials.gov More Congenital Disorders trials